Beijing Med-Pharm Corporation to Present at the UBS Global Generic and Specialty Pharmaceuticals Conference
Posted on: Monday, 7 May 2007, 09:00 CDT
Beijing Med-Pharm Corporation (Nasdaq:BJGP) today announced that it will present at the UBS Global Generic and Specialty Pharmaceuticals Conference at 1:30 p.m. Eastern Time on Wednesday, May 9, at the Grand Hyatt New York in New York City.
Beijing Med-Pharm Chairman Martyn Greenacre will present an update on corporate activities, including progress with recently announced joint ventures and acquisitions in China. A live audio webcast of the presentation will be available at http://www.ibb.ubs.com, by following the "Conferences" link and selecting the Webcast for the 2007 Global Generic and Specialty Pharmaceuticals Conference. An audio replay will be accessible by 5:00 p.m., May 9, and remain available until June 8, 2007. A link to the webcast will also be posted at http://www.beijingmedpharm.com.
About Beijing Med-Pharm Corporation
Beijing Med-Pharm is a pharmaceutical marketing and distribution company that is building a proprietary portfolio of high-value branded pharmaceutical products in China and pursuing partnerships with other companies seeking to enter the Chinese pharmaceuticals market. Beijing Med-Pharm is the only U.S. public company to offer industry partners a comprehensive suite of market-entry services in China that includes pre-market entry analysis; clinical trial management; product registration; market research; pharmaceutical distribution to hospitals through a unique proprietary network; and pharmaceutical marketing to physicians, hospitals and other healthcare providers.
Source: Business Wire
Related Articles
- Kyp Systems Takes on the Challenge of New Pharmaceutical Marketing Guidelines
- Examine in Detail China's Pharmaceutical Market and Health Care Reform
- URCH Publishing Releases Market Report on China's Pharmaceutical Regulations
- Examine the Challenges and Opportunities for Investment in the Chinese Pharmaceutical Market
- Must Know Business and Marketing Strategy for China's Pharmaceutical Market
- Global Pharmaceutical Market to Double in Value to $1.3 Trillion By 2020, Estimates PricewaterhouseCoopers, But Industry Must Change to Capitalize On Opportunities
- IMS Health Reports Global Pharmaceutical Market Grew 7.0 Percent in 2006, to $643 Billion
- Alliance Boots to Enter Chinese Pharmaceutical Market
- Research and Markets: New Research Provides an In-Depth Look at the Russian Pharmaceutical Market
- Research and Markets: Key Insights into Russia's Pharmaceutical Market
User Comments (0)

RSS Feeds